$237.5 million is the market’s projected 2026 size, with Future Market Insights forecasting growth to $813.4 million by 2036.
13.1% annual growth is tied to demand for compact wellness formats that can show active-ingredient evidence, dose consistency, taste acceptance and compliant claims before buyers scale orders.
Fast-dissolve strips are expected to lead delivery formats with a 37.3% share in 2026, while caffeine plus L-theanine holds 30.2% of active ingredients and the focus benefit segment takes 32.2%.
North America is projected to hold a 35.9% regional share in 2026, but India posts the fastest country CAGR at 12.1%, ahead of China’s 10.7% and the U.S. at 9.3%.
FDA CGMP rules, NIH supplement guidance and EFSA references remain central to supplier selection, making documentation and claim discipline a key constraint as brands push beyond trial runs.